Martin Shkreli weighs in on the rising costs of EpiPens, fraud charges
The cost of EpiPens are on the rise. Founder and former CEO of Turing Pharmaceuticals, Martin Shkreli, joins CBSN with to discuss why he believes the price hike is justified and why he raised the price of Daraprim by 5000%.
Видео Martin Shkreli weighs in on the rising costs of EpiPens, fraud charges канала CBS News
Видео Martin Shkreli weighs in on the rising costs of EpiPens, fraud charges канала CBS News
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Martin Shkreli Testifies Before Congress: Full Testimony | CNBCMartin Shkreli: Daraprim Has Always Been AffordableEmbattled pharma CEOs infamy continues on TwitterMartin Shkreli Interview at The Breakfast Club Power 105.1 (02/03/2016)Martin Shkreli On Verdict: This Was A Witch Hunt Of Epic Proportions | CNBCShkreli: Price Increase Has Stuck, Happy With ThatMartin Shkreli on Drug Price Hikes and Playing the World’s VillainTuring CEO Martin Shkreli Talks 5,000% Drug Price Hike (Full Interview) | CNBCRep. Chaffetz questions Mylan CEO Heather Bresch on EpiPen prices (C-SPAN)Top 5 Facts about Martin ShkreliMylan CEO: EpiPen $608 Price Was 'Fair'Shkreli: It's unethical to drag me in front of Congress to plead the 5thMartin Shkreli's Attorney: Former Turing Pharma CEO Is A 'Genius' | CNBCMartin Shkreli: 'I Would've Raised Prices Higher' | ForbesAttorney: Martin Shkreli Has 'Perfect Right' To Invoke Fifth Amendment | CNBCFNN: House Hearing on Drug Pricing - Martin Shkreli Refuses to TestifyMartin Shkreli: Trump's going to make pharma great againTuring CEO defends 5,000% price increase on AIDS drugMartin Shkreli: First interview after trialFBI Arrest Pharma CEO Martin Shkreli In NYC | MSNBC